Castle Biosciences price target raised to $45 from $40 at BTIG
BTIG raised the firm’s price target on Castle Biosciences (CSTL) to $45 from $40 and keeps a Buy rating on the shares. The company ...
Tactile Systems cut to Neutral at BTIG after Q3 revenue miss
Tactile Systems (TCMD) stock was downgraded by BTIG to neutral as its Q3 revenue misses expectations. Read more here.
bovnews1d
Why Did BTIG Research Give Capital One Financial Corp. (COF) Stock Neutral Rating?
BTIG Research has recently initiated Capital One Financial Corp. (COF) stock to Neutral rating, as announced on June 7, 2024, according to Finviz. Earlier, on June 6, 2024, Jefferies had raised the ...
Business Insider1d
BTIG Reaffirms Their Buy Rating on Revolve Group (RVLV)
BTIG analyst Janine Stichter maintained a Buy rating on Revolve Group (RVLV – Research Report) yesterday and set a price target of $30.00. The company’s shares closed yesterday at $25.27. According ...
Yahoo Finance5d
Wingstop lifted to Buy at BTIG, 'multiple levers remain'
Investing.com -- BTIG upgraded Wingstop (NASDAQ:WING) to Buy with a price target of $370 on Thursday, citing opportunities for long-term growth despite recent concerns around the company's fourth ...
BTIG Research Upgrades Wingstop (NASDAQ:WING) to Buy
BTIG Research upgraded shares of Wingstop (NASDAQ:WING – Free Report) from a neutral rating to a buy rating in a research ...
sgbonline13d
EXEC: Hoka Parent Gets October Surprise Downgrade; Others Say Not So Fast
The October 22 report on Hoka noted signs that the running footwear brand’s multi-year growth is moderating. The firm also ...
Stocks are poised for some downside volatility over the coming weeks, says BTIG's Krinsky
The S&P 500 was rising 0.3% on Tuesday afternoon, on pace for the 28th consecutive trading day where the large-cap benchmark index moved less than 1% in either direction, according to FactSet data.
Nasdaq6d
Wingstop upgraded to Buy from Neutral at BTIG
BTIG upgraded Wingstop (WING) to Buy from Neutral with a $370 price target The analyst cites the post-earnings selloff in the shares for the upgrade. The decline below $300 represents an ...
Yahoo Finance22d
Castle Biosciences price target raised to $40 from $35 at BTIG
BTIG raised the firm’s price target on Castle Biosciences (CSTL) to $40 from $35 and keeps a Buy rating on the shares. The firm is citing its call with a key opinion leader Dr. Raman Muthusamy ...
Business Insider1d
BTIG Sticks to Its Buy Rating for GE Healthcare Technologies Inc (GEHC)
BTIG analyst Ryan Zimmerman maintained a Buy rating on GE Healthcare Technologies Inc (GEHC – Research Report) yesterday and set a price target of $99.00. The company’s shares closed yesterday at ...